loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 50740 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Astellas Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 AMPHOTERICIN B (1)

    filter

    01 ASTELLAS (1)

    filter

    01 INJECTABLE, LIPOSOMAL;INJECTION (1)

    filter

    01 50MG/VIAL (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Amphotericin B

    PDF Supplier PDF
    URL Supplier Web Content
    INJECTABLE, LIPOSOMAL;...
    50MG/VIAL
    AMBISOME
    USA
    50740
    1997-08-11
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 50740

    Looking for CTD TGA MCC DOSSIER APPLICATION 50740 1

    19

    Astellas Pharma, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is AMPHOTERICIN B, with a corresponding application number 50740 and regulatory information .

    proudly manufactured in the

    approval since 1997-08-11

    Astellas Pharma's AMBISOME INJECTABLE, LIPOSOMAL;INJECTION, medication with 50MG/VIAL of AMPHOTERICIN B.

    Post Enquiry
    POST ENQUIRY